The following are clinical studies and trials relevant to women s health. The study will follow subjects for up to five years to determine if estrogen therapy reduces the risk of death or recurrence of stroke. The goal of this carefully controlled trial is to verify the findings of previous epidemiological studies. The WEST study is significant for the promise it holds for stroke treatment in general and for the potential health benefit to postmenopausal women in particular.
Women are three times more likely to suffer migraine headaches than men.
About 70,000 annual births occur at these large centers, including a substantial number of premature deliveries. Additionally, babies exposed to maternal infection exhibited more often detrimental findings such as low Apgar scores, need for respirator and early seizures. The investigators plan to develop specific hypotheses to test if maternal infections endanger the brain of the fetus. The study examined levels of cytokines and coagulation factors in blood taken shortly after birth. The results showed that all the babies who later developed CP had elevated concentrations of one or more coagulation factors and inflammation markers.